Vik Meadows

1.1k total citations
32 papers, 484 citations indexed

About

Vik Meadows is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Vik Meadows has authored 32 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 15 papers in Hepatology and 13 papers in Surgery. Recurrent topics in Vik Meadows's work include Drug Transport and Resistance Mechanisms (13 papers), Liver Disease Diagnosis and Treatment (12 papers) and Liver Diseases and Immunity (12 papers). Vik Meadows is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Liver Disease Diagnosis and Treatment (12 papers) and Liver Diseases and Immunity (12 papers). Vik Meadows collaborates with scholars based in United States, Italy and Netherlands. Vik Meadows's co-authors include Lindsey Kennedy, Heather Francis, Gianfranco Alpini, Debjyoti Kundu, Shannon Glaser, Tianhao Zhou, Konstantina Kyritsi, Burcin Ekser, Leonardo Baiocchi and Lixian Chen and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

In The Last Decade

Vik Meadows

29 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vik Meadows United States	14	204	165	156	98	94	32	484
Debjyoti Kundu United States	12	161 0.8×	138 0.8×	131 0.8×	76 0.8×	70 0.7×	24	385
Ludovica Ceci Italy	14	226 1.1×	159 1.0×	143 0.9×	62 0.6×	130 1.4×	33	537
Jain Jeong South Korea	12	127 0.6×	107 0.6×	77 0.5×	73 0.7×	185 2.0×	28	509
Harrison T. Muturi United States	12	155 0.8×	53 0.3×	97 0.6×	90 0.9×	224 2.4×	27	480
Cheryl Galindo United States	6	105 0.5×	105 0.6×	88 0.6×	133 1.4×	162 1.7×	11	432
Marina Nati Germany	7	255 1.3×	69 0.4×	33 0.2×	26 0.3×	110 1.2×	8	417
Christian Jaeger Luxembourg	12	57 0.3×	32 0.2×	63 0.4×	83 0.8×	184 2.0×	13	518
Angelika Jurdzinski Netherlands	10	119 0.6×	21 0.1×	145 0.9×	98 1.0×	323 3.4×	19	598
Ramona Reichenbach Italy	4	73 0.4×	181 1.1×	233 1.5×	120 1.2×	68 0.7×	6	417
Anna P. Koh United States	7	46 0.2×	69 0.4×	42 0.3×	39 0.4×	118 1.3×	11	382

Countries citing papers authored by Vik Meadows

Since Specialization

Citations

This map shows the geographic impact of Vik Meadows's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vik Meadows with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vik Meadows more than expected).

Fields of papers citing papers by Vik Meadows

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vik Meadows. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vik Meadows. The network helps show where Vik Meadows may publish in the future.

Co-authorship network of co-authors of Vik Meadows

This figure shows the co-authorship network connecting the top 25 collaborators of Vik Meadows. A scholar is included among the top collaborators of Vik Meadows based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vik Meadows. Vik Meadows is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yasaka, Tyler M., et al.. (2025). Zonation, Zonation, Zonation: The Real Estate of the Liver. Annual Review of Pathology Mechanisms of Disease. 21(1). 185–212.

Delgado, Evan R., Junyan Tao, Silvia Liu, et al.. (2025). Glutamine synthetase loss in β-catenin–mutant hepatocellular carcinoma promotes tumor burden through macrophage metabolic reprogramming. Hepatology.

Meadows, Vik, Daniel Rizzolo, Peihong Zhou, et al.. (2025). Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXR. PubMed. 3(3). e100227–e100227.

Kong, Bo, Ill Yang, Anita Brinker, et al.. (2024). Effects of therapeutically approved individual bile acids on the development of metabolic dysfunction-associated steatohepatitis a low bile acid mouse model. Toxicological Sciences. 202(2). 179–195. 2 indexed citations

Meadows, Vik, Peihong Zhou, Laurie B. Joseph, et al.. (2024). Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model. Toxicological Sciences. 199(2). 316–331. 6 indexed citations

Flores, Juan, Panan Suntornsaratoon, Vik Meadows, et al.. (2024). The arginine and nitric oxide metabolic pathway regulate the gut colonization and expansion of Ruminococcous gnavus. Journal of Biological Chemistry. 300(9). 107614–107614. 5 indexed citations

Meadows, Vik, et al.. (2024). Ruminococcus gnavus in the gut: driver, contributor, or innocent bystander in steatotic liver disease?. FEBS Journal. 292(6). 1252–1264. 6 indexed citations

Kundu, Debjyoti, Lindsey Kennedy, Tianhao Zhou, et al.. (2023). p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling. Hepatology. 78(1). 243–257. 12 indexed citations

Meadows, Vik, et al.. (2023). FXR Friend-ChIPs in the Enterohepatic System. Seminars in Liver Disease. 43(3). 267–278. 4 indexed citations

10.

Meadows, Vik, et al.. (2023). FXR and NASH: an avenue for tissue-specific regulation. Hepatology Communications. 7(5). 19 indexed citations

11.

Kennedy, Lindsey, Guido Carpino, Ludovica Ceci, et al.. (2022). Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes. Journal of Hepatology. 78(1). 99–113. 26 indexed citations

12.

Meadows, Vik, Leonardo Baiocchi, Debjyoti Kundu, et al.. (2021). Biliary Epithelial Senescence in Liver Disease: There Will Be SASP. Frontiers in Molecular Biosciences. 8. 803098–803098. 26 indexed citations

13.

Wu, Nan, Guido Carpino, Ludovica Ceci, et al.. (2021). Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury. Hepatology. 75(4). 797–813. 21 indexed citations

14.

Meadows, Vik, Lindsey Kennedy, Debjyoti Kundu, Gianfranco Alpini, & Heather Francis. (2020). Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases. PMC. 3 indexed citations

15.

Meadows, Vik, Lindsey Kennedy, Debjyoti Kundu, Gianfranco Alpini, & Heather Francis. (2020). Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases. Frontiers in Medicine. 7. 15–15. 23 indexed citations

16.

Kennedy, Lindsey, Vik Meadows, Jennifer Demieville, et al.. (2020). Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling. Laboratory Investigation. 100(6). 837–848. 20 indexed citations

17.

Kennedy, Lindsey, Vik Meadows, Konstantina Kyritsi, et al.. (2020). Amelioration of Large Bile Duct Damage by Histamine-2 Receptor Vivo-Morpholino Treatment. American Journal Of Pathology. 190(5). 1018–1029. 13 indexed citations

18.

Pham, Linh, Leonardo Baiocchi, Lindsey Kennedy, et al.. (2020). The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators. Journal of Pineal Research. 70(2). e12699–e12699. 47 indexed citations

19.

Ceci, Ludovica, Heather Francis, Tianhao Zhou, et al.. (2020). Knockout of the Tachykinin Receptor 1 in the Mdr2−/− (Abcb4−/−) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver Fibrosis. American Journal Of Pathology. 190(11). 2251–2266. 10 indexed citations

20.

Meadows, Vik, Lindsey Kennedy, Laura Hargrove, et al.. (2019). Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2−/− mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(12). 165557–165557. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact